top of page

The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis
PICaSSO Histologic Remission Index (PHRI) in ulcerative colitis: development of a novel simplified histological score for monitoring...
IBDENC ENC
Mar 2, 2022
0


Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in IBD
Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease R. Mahmoud,J.P.D....
IBDENC ENC
Feb 18, 2022
0
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS
SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE...
IBDENC ENC
Feb 17, 2022
0
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to
The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD):...
IBDENC ENC
Feb 16, 2022
0
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation
Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal...
IBDENC ENC
Feb 16, 2022
0
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset IBD: Systematic Review
Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review M. Ellen...
IBDENC ENC
Feb 16, 2022
0
Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic
Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Guan Y, Hao...
IBDENC ENC
Feb 10, 2022
0
Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check
Disease Prognostic Biomarkers in Inflammatory Bowel Diseases—A Reality Check Matthias Zilbauer, Robert Heuschkel Published in Journal of...
IBDENC ENC
Feb 10, 2022
0
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched resea
Incidence, outcomes, and impact of COVID-19 on inflammatory bowel disease: propensity matched research network analysis Yousaf Hadi,...
IBDENC ENC
Feb 4, 2022
0
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed
First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease:...
IBDENC ENC
Feb 3, 2022
0
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts
Alcohol consumption and risk of inflammatory bowel disease among three prospective US cohorts Kevin Casey, Emily W Lopes, Blake Niccum,...
IBDENC ENC
Feb 2, 2022
0


Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel...
IBDENC ENC
Jan 8, 2022
0
bottom of page